BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18385356)

  • 1. The functional state of the complement system in leprosy.
    Gomes GI; Nahn EP; Santos RK; Da Silva WD; Kipnis TL
    Am J Trop Med Hyg; 2008 Apr; 78(4):605-10. PubMed ID: 18385356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of complement by circulating immune complexes isolated from leprosy patients.
    Tyagi P; Ramanathan VD; Girdhar BK; Katoch K; Bhatia AS; Sengupta U
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):31-8. PubMed ID: 2319186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms.
    Dornelles LN; Pereira-Ferrari L; Messias-Reason I
    Clin Exp Immunol; 2006 Sep; 145(3):463-8. PubMed ID: 16907914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme immunoassay of phagocytosis stimulating tetrapeptide "tuftsin" in normal and leprosy sera.
    Kaur J; Khare S; Bhutani LK; Rao DN
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):576-81. PubMed ID: 1802940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of serum lipids and lipoproteins in leprosy.
    Ahaley SK; Sardeshmukh AS; Suryakar AN; Samson PD
    Indian J Lepr; 1992; 64(1):91-8. PubMed ID: 1573306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
    George J; Bhatia VN; Balakrishnan S; Ramu G
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced complement-mediated immune complex solubilization in leprosy patients.
    Ramanathan VD; Sharma P; Ramu G; Sengupta U
    Clin Exp Immunol; 1985 Jun; 60(3):553-8. PubMed ID: 3874729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions.
    Beuria MK; Mohanty KK; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum complement profile in human leprosy and its comparison with immune complex diseases.
    Saha K; Chakraborty AK
    Int J Lepr Other Mycobact Dis; 1977; 45(4):327-37. PubMed ID: 147246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of circulating immune complexes in leprosy.
    Ramos GS; Bottasso OA; Morini JC; Segal-Eiras A
    Rev Argent Microbiol; 1988; 20(4):163-70. PubMed ID: 3247413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization of preformed immune complexes in sera of patients with type 1 and type 2 lepra reactions.
    Chakrabarty AK; Kashyap A; Sehgal VN; Saha K
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):559-65. PubMed ID: 3221112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone profile in leprosy.
    Garg R; Agarwal JK; Singh G; Bajpai HS
    Indian J Lepr; 1989 Oct; 61(4):428-31. PubMed ID: 2516097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte superoxide dismutase, catalase activities and hydrogen peroxide induced lipid peroxidation in leprosy.
    Prasad CV; Kodliwadmath MV; Kodliwadmath GB
    Lepr Rev; 2007 Dec; 78(4):391-7. PubMed ID: 18309714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose tolerance test in leprosy.
    Garg R; Agrawal JK; Bajpai HS; Singh G; Srivastava PK
    Indian J Lepr; 1990; 62(1):50-4. PubMed ID: 2358705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
    Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte glutathione peroxidase, glutathione reductase activities and blood glutathione content in leprosy.
    Prasad CV; Kodliwadmath MV; Kodliwadmath GB
    J Infect; 2008 Jun; 56(6):469-73. PubMed ID: 18440071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A concentration method for detection and quantitation of bacillaemia in leprosy and its comparison with other techniques.
    Nagesha CN; Mallya S; Parvathi CN; Shetty JN
    Lepr Rev; 1988 Dec; 59(4):337-40. PubMed ID: 3072457
    [No Abstract]   [Full Text] [Related]  

  • 19. A study on the methods for early serological diagnosis of leprosy and their potential use.
    Wu Q; Li X; Yin Y; Shu H; Wei W; Liu Q; Ye G
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):302-5. PubMed ID: 10575411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
    Mohanty KK; Joshi B; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.